<DOC>
	<DOCNO>NCT00831220</DOCNO>
	<brief_summary>Objective : To investigate potential role endothelial dysfunction pathogenic mechanism cardiovascular event COPD . Hypothesis : endothelial function abnormal patient COPD , particularly exacerbation disease . Design : prospective control study perform university hospital . Population : compare 4 group subject , 44 patient stable COPD , 35 patient acute exacerbation COPD , 10 smoker former smoker normal lung function 10 never smoker match physical activity BMI . Study variable : ) clinical variable : clinical information , physical examination , pulmonary function test , ECG sputum culture ; b ) Biological variable : number Circulating Endothelial Progenitor Cells , vascular growth factor ( vascular endothelial growht factor erythropoietin ) , systemic inflammation ( C-reactive protein , white blood cell ) , peripheral venous blood test ( include hemogram , biochemical analysis glycemia , cholesterol , LDLcol , HDLcol ) ; c ) systemic vascular reactivity assessment .</brief_summary>
	<brief_title>Endothelial Dysfunction Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Patients moderate severe COPD admit hospital exacerbation , , Patients moderate severe COPD stable condition . Patients exacerbation COPD need invasive non invasive mechanical ventilation Patients chronic inflammatory disease . Patients acute active chronic systemic disease heart failure , renal insufficiency , etc .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>COPD</keyword>
	<keyword>exacerbation</keyword>
	<keyword>EPCs</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>C-RP</keyword>
	<keyword>COPD endothelial dysfunction</keyword>
</DOC>